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 ABSTRACT 
Dielectrophoresis – the motion of particles in non-uniform AC fields – has been used in the 
investigation of cell electrophysiology.  The technique offers the advantages of rapid determination of the 
conductance and capacitance of membrane and cytoplasm.  However, it is unable to directly determine the 
ionic strengths of individual cytoplasmic ions, which has potentially limited its application in assessing 
cell composition.  In this paper, we demonstrate how dielectrophoresis can be used to investigate the 
cytoplasmic ion composition by using ion channel blocking agents.  By blocking key ion transporters 
individually, it is possible to determine their overall contribution to the free ions in the cytoplasm.  We use 
this technique to evaluate the relative contributions of chloride, potassium and calcium ions to the 
cytoplasmic conductivities of drug sensitive and resistant myelogenous leukaemic (K562) cells in order to 
determine the contributions of individual ion channel activity in mediating multi-drug resistance in cancer.  
Results indicate that whilst K+ and Ca2+ levels were extremely similar between sensitive and resistant 
lines, levels of Cl- were elevated by three times that in the resistant line, implying increased chloride 
channel activity. This result is in line with current theories of MDR, and validates the use of ion channel 
blockers with DEP to investigate ion channel function. 
 
  
 
 1 INTRODUCTION 
Dielectrophoresis (DEP) is a phenomenon of induced particle motion on the micro- and nano-
scale, with a broad range of applications to medicine (Pohl 1978, Hughes 2002).  It belongs to a family of 
electrical phenomena that includes the more commonly used technique of electrophoresis, but is 
functionally different in two aspects.  First, it is more readily amenable for use with whole cells; second, it 
uses an alternating (rather than constant) energizing voltage whose frequency is swept over a wide range, 
producing a spectrum that allows the analyst to determine the electrical properties (typically capacitance 
and electrical conductivity) of the membrane and cytoplasm (rather than merely the net particle charge).  
Furthermore, DEP is label-free and non-invasive, relying on the measurement of cell motion in non-
uniform electric fields to infer the electrical properties.  However, it is unable to directly determine the 
ionic strengths of individual cytoplasmic ions, which has potentially limited its application in assessing 
cell composition; in this paper, we demonstrate how dielectrophoresis can be used to investigate the 
cytoplasmic ion composition by using ion channel blocking agents.    Our previous work (Labeed et al 
2003) has shown that drug sensitive (K562) and doxorubicin resistant leukaemic (K562AR) cancer cells 
exhibited significant differences in their dielectric properties, most notably in the conductivity (related to 
free ions) of the cytoplasm. K562 cells exhibited lower cytoplasmic conductivity- ionic strength relative to 
K562AR. Broader studies (Coley et al 2007) have indicated that there is a direct correlation between drug 
resistance and cytoplasmic conductivity.   
Cancer cell resistance to chemotherapeutic agents can present a serious impediment to the 
successful treatment of cancer and is responsible for many deaths each year. One form of drug resistance 
is called multidrug resistance (MDR), characterised by cross-resistance to many anti-cancer drugs that 
have no common structure – but which are notably natural product in origin. Several mechanisms have 
been attributed to the MDR phenotype. A common correlate of MDR is the over-expression of membrane 
glycoproteins, collectively termed ABC (ATP-binding-cassette) transporters. Specifically, the MDR1 gene 
product P-glycoprotein pump (P-gp) has been closely associated with MDR status in cells.  However, 
there is no clear consensus regarding the way in which P-gp confers drug resistance; rather, two models of 
MDR have been proposed, based on different aspects of P-gp activity.  It has been postulated to play a 
direct role in drug efflux, “pumping” drugs (which act as substrates for the pump) from the membrane and 
giving rise to reduced and ineffective intracellular drug concentrations (Juliano and Ling 1976, Gottesman 
et al 2002). However, P-gp has also been reported to be a Cl- channel (Valverde et al 1992, Wadkins et al 
1997) or bifunctional with one function as a Cl- channel and another as a peptide transporter (Gill et al 
1992).  It has also been noted that P-gp shares homology with the cystic fibrosis transmembrane 
conductance regulator (CFTR) (Welsh et al 1992, Gadsby et al 1999), a known Cl- channel.   
In this paper, we have used DEP to determine the relative contributions of chloride, potassium and 
calcium ions to the cytoplasmic conductivity of drug-sensitive and drug-resistant (P-gp expressing) 
leukaemic cells in order to determine the contributions of individual ion channel activity in mediating 
multi-drug resistance in cancer.  K562 and K562AR cells were separately cultured with agents to 
specifically block calcium, chloride and potassium (verapamil, NPPB and quinine, respectively).  This 
allowed a determination of the contribution of each ion species to the net conductivity of the untreated cell 
and, hence, showed the quantity of specific ion species present in the cells.  Results indicate that whilst K+ 
and Ca2+ levels were extremely similar between sensitive and resistant line, levels of Cl- were elevated by 
up to three times in the resistant line, implying increased chloride channel activity that can be associated 
with P-gp overexpression and supports the notion of P-gp as a chloride channel.  However, treatment 
using the MDR modulator XR9576 (Roe et al 1999) showed no change in cytoplasmic conductivity 
despite reversing drug resistance.  This correlates with the dual-function role of P-gp (Wadkins et al 1997) 
and indicates that its function as a chloride transporter plays no significant role in conferring MDR status 
in cells.  
 
 
 
 
2. THEORY 
 
A dielectrophoretic force occurs due to the interaction of an induced dipole and an electric field gradient.  
The time averaged force FDEP on a homogeneous dielectric sphere, (Hughes 2002) is: 
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where r is the particle radius, εm  is the absolute permittivity of the suspending medium, ∇  the del vector 
operator, Erms is the local RMS electric field and Re[K(ω)] is the real part of the Clausius-Mossotti factor, 
given by: 
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where εm* and εp* are the complex permittivities of the medium and particle respectively. A general 
permittivity is defined as 
ω
σ
εε j−=∗   with permittivity ε and conductivity σ. The direction of the force 
(positive or negative DEP) is governed by the value of Re[K(ω)], which can take positive or negative 
values respectively depending on the applied frequency or the particle and suspending medium 
conductivity and permittivity.  We can adapt this for a more complex sphere such as a cell, where the 
inner cytoplasm is enclosed by an enveloping membrane.  If we consider the cytoplasm as being 
compartment 1 and having radius a1 surrounded by the membrane which we consider as compartment 2 
and have radius a2, then we can replace the complex permittivity of the particle εp* with an effective 
particle permittivity ε*1eff formed from the combined properties of membrane and cytoplasm, thus (Hughes 
2002): 
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This value provides an expression for the combined complex permittivity of the particle at any given 
frequency ω.  It can also be combined with the complex permittivity of the medium to calculate the 
Clausius-Mossotti factor.   
 We propose that by using this model in conjunction with ion channel blockers, it is possible to 
determine the relative contribution of major ion species in the cytoplasm.  The cytoplasmic conductivity is 
the net product of the mobile ionic species contained within the cytoplasm; when the cell membrane is 
allowed to permeabilise, the cytoplasmic conductivity drops to single-mS values (Hübner et al 2005). We 
hypothesise that if ion channel-blocking agents are used, the cytoplasmic conductivity will drop due to the 
absence of the corresponding ion species in the cytoplasm; if a range of ion channel blockers is used and 
key ion species are removed one at a time, then by simple algebra it should be possible to determine the 
actual contribution of each ion species to the total conductivity, and hence to determine the relative 
concentration of each ion species in the cytoplasm of the cells. 
  
3. MATERIALS AND METHODS 
 
1.1 Chemicals and reagents 
Doxorubicin was dissolved in sterile distilled water and stored frozen as  stock solutions, which 
were thawed prior to use. The 5-Nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) was dissolved in 
dimethylsulfoxide, and water was used for quinine and verapamil. All reagents were purchased from 
Sigma Aldrich, Poole, UK.  XR9576 was prepared as described in detail by Labeed et al (2003). 
 
1.2 Cell culture and ion channel blockers  
Human chronic myelogenous leukaemia (K562), and its doxorubicin resistant counterpart 
(K562AR), were grown in 20 mM HEPES modified RPMI-1640 medium supplemented with 10% heat-
inactivated foetal calf serum (FCS), (Invitrogen, Paisley, UK), 2 mM L- glutamine and 100 units/ mL 
penicillin-streptomycin. All cell culture reagents were obtained from Sigma Aldrich (Poole, UK), unless 
stated otherwise. The cells were grown under standard cell culture conditions with 5% CO2 / 95% air at 
37°C. K562AR were maintained in the presence of 100nM doxorubicin which was removed at least 1 
passage prior to use of cells in experiments. 
A density of 3×105 cells per mL was used for ion channel blocker treatments, and the cells were incubated 
for two hours prior to DEP analysis. This procedure was followed for each agent: 20 µM verapamil, 10 
µM NPPB and 0.1 mM quinine, 100nM XR9576.   
The MDR status of K562AR has been confirmed previously (data not shown, for similar results 
see previous work Labeed et al 2003) using western immunoblotting and MTT-cytotoxicity testing. These 
previous analyses confirmed the overexpression of P-gp, for K562AR cells, whilst cytotoxicity testing 
showed them to be 14 fold resistant to doxorubicin relative to K562 parental cells. 
 
1.3 DEP experiments 
The drug resistant and sensitive cells were centrifuged at room temperature at 190 ×g for 5 
minutes. The pellets were washed and resuspended in iso-osmotic medium consisting of 8.5% (w/v) 
sucrose plus 0.3% (w/v) dextrose buffer (Gascoyne et al 1997). The medium conductivity was adjusted to 
2.5 mS/m using PBS and the final conductivity, before use, was verified with a conductivity meter (RS 
components Ltd, London, UK). The final cell population was counted using a haemocytometer and 
adjusted to approximately 3x105 cells/ mL (±15%) for DEP measurements.  In order to reduce the effect of 
variation in cell number in each sample, the experiments were repeated many times (generally 4-6) with 
different populations, which were summed prior to modelling.  
The dielectric properties of the cells, after each ion channel blocker were determined by fitting the 
measurement spectra to the single shell model (Broche et al 2005). The best fit model was found by 
matching the curve to the measured data, and then altering the dielectric parameters of the membrane and 
the cytoplasm until a best match was found.  For DEP calculations, cell diameters were measured using 
Photolite software to analyse microscope images of cells. 
 
2 RESULTS AND DISCUSSION 
 
DEP spectra were taken for K562 and K562AR before and after treatment with ion channel 
blockers, and the dielectric properties of the cells were extracted using principles outlined by Broche et al. 
(2005), with particular attention paid to the conductivity of the cytoplasm (σcyto).  This parameter 
represents the conduction of free ions through the cytoplasm, and is composed of the sum of the 
contributions of the ion species present.  The values of cytoplasmic conductivity for control cells and 
those having been incubated with the blockers, plus data for cells incubated with XR9576, are shown in 
Table 1. 
The results showed significant differences in the cytoplasm of the drug sensitive K562 relative to 
drug resistant counterparts.  This difference has already been described in the literature (Labeed et al 
2003) but its origin has not been discussed.  As shown in Table 1, untreated control K562 cells exhibit a 
lower σcyto (0.28 S/m) relative to the control drug resistant counterpart (0.50 S/m). Treating both cell lines 
with verapamil (a calcium channel blocker) and quinine (a potassium channel blocker) caused 
approximately the same degree of reduction in the σcyto (approximately   -0.1S/m and -0.15S/m 
respectively). However, using NPPB (a chloride channel blocker) resulted in significantly different 
changes in the two lines, with both cell lines exhibiting the same σcyto (0.25 S/m) values after treatment.  
Notably, treating either cell line with XR9576 produced no significant change in the value of σcyto. 
In order to understand these results, it is necessary to make an approximation.  We suggest that we 
can consider the cell to be composed of three primary conducting agents –  K+, Ca2+ and Cl- - plus some 
minor contribution from other charged species (DNA and proteins), whose value (observed in cells that 
have lost membrane integrity) can be at least an order of magnitude less than for viable cells (Labeed et al 
2006).  Assuming that each blocker selectively removes one ion species from this list, a simultaneous 
equation can be constructed to determine the contribution each ion makes to the total value of cytoplasmic 
conductivity.  We emphasise that this process is an approximation, since factors such as conductivity 
change due to water loss (Labeed et al 2006) are not considered – there was no significant change 
observed in the radii of K562 cells after treatment, but some shrinkage was seen in blocker-treated 
K562AR – but the results do highlight trends in the ionic composition of the two species. 
Considering the results, we found that a good match was found to the data for ionic contributions 
for K+, Ca2+ and Cl- of 0.13Sm-1, 0.08 Sm-1 and 0.09 Sm-1 for K562, and 0.16, 0.08 and 0.25 Sm-1 for 
K562AR.  Assuming an error margin of 10%, it is evident that for K+ and Ca2+ the values are sufficiently 
similar to suggest that they are the same between the two lines; however, the data suggest there is a 
significant (three-fold) difference in cellular chloride levels between parent and resistant lines.   
This result is significant for two reasons.  First, it indicates that the primary electrophysiological 
difference in the two lines can be attributed to the presence of additional chloride, suggesting either an 
increase in activity of chloride channels in the resistant line.  This strongly correlates with the notion that 
P-gp is a chloride channel. However, it is also important to note that the MDR modulator XR9576 does 
not change the electrical properties of the cell – that is to say, the drug resistance of the cell is not affected 
by the chloride channel activity of P-gp, but by another mechanism which inhibits resistance without 
affecting the chloride channel function of the P-gp molecule.   
In summary, we have demonstrated that the use of ion channel blockers allows the approximate 
determination of cytoplasmic ionic composition, and hence the quantify the activity of ion channels non-
invasively in large numbers of cells simultaneously.  The results indicate that the membrane protein P-gp 
does act as a chloride channel, but that this function is neither correlated with the conferring of MDR 
status, nor deactivated by the inhibition of P-gp in resistance modulation.  .  
 
 AKNOWLEDGEMENTS 
We thank the Nuffield Bursary scheme for funding HS, and Xenova PLC (Millenium) for the supply of 
XR9576. 
 
REFERENCES 
Broche L, Labeed F H and Hughes M P 2005 Extraction of dielectric properties for multiple populations 
from dielectrophoretic collection spectrum data, Phys. Med. Biol. 50 2267-74. 
Coley H M, Labeed F H, Thomas H and Hughes M P 2007 Biophysical characterization of multidrug 
resistance in MCF-7 cell lines reveals the cytoplasm is a critical factor determining drug sensitivity 
Biochim. Biophys. Acta, 1770 601-08. 
Gadsby D C and Nairn A C 1999 Regulation of CFTR Cl- ion channels by phosphorylation and 
dephosphorylation Adv. Sec. Mess. Phosph. 33 79-106. 
Gascoyne P R C, Wang X B, Huang Y and Becker F F 1997 Dielectrophoretic separation of cancer cells 
from blood, IEEE Trans. Ind. Appl. 33 670-78. 
Gill D R, Hyde S C, Higgins C F, Valverde M A, Mintenig G M and Sepulveda F V 1992 Separation of 
drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein Cell 71 
23-32. 
Gottesman M M, Fojo T and Bates S E 2002 Multidrug resistance in cancer; role of ATP-dependent 
transporters Nature Rev. Cancer 2  48-58. 
Hübner Y, Hoettges K F, Kass G E N,  Ogin S L and Hughes M P 2005 Parallel measurements  of drug 
actions on Erythrocytes by dielectrophoresis, using a novel 3-dimensional electrode design IEE Proc. 
Nanobiotech. 4 21-25 
Hughes M P 2002 Nanoelectromechanics in Engineering and Biology, CRC Press, Boca Raton. 
Juliano R L and Ling V A 1976 A surface glycoprotein modulating drug permeability in Chinese 
hamster ovary cell mutants Biochim. Biophys. Acta 255 152-62. 
Labeed F H, Coley H M, Thomas H and Hughes M P 2003 Assessment of multidrug resistance reversal 
using dielectrophoresis and flow cytometry, Biophys. J. 85 2028-34. 
Labeed F H, Coley H M and Hughes M P 2006 Changes in the cytoplasm of K562 myelogeneous 
leukaemic cancer cells during apoptosis, observed in real time by dielectrophoresis, Biochim. Biophys. 
Acta. 1760 922-29.  
Pohl H A 1978 Dielectrophoresis, Cambridge University Press, Cambridge. 
Valverde M A, Diaz M, Sepulveda F V, Gill D R, Hyde S C and Higgins C F 1992 Volume-regulated 
chloride channels associated with the human multidrug-resistance P-glycoprotein Nature 355 830-33. 
Wadkins R M and Roepe P D 1997 Biophysical aspects of P-glycoprotein-mediated multidrug resistance 
Int. Rev. Cytol. 171 121-65.  
Welsh M J, Anderson M P, Rich D P, Berger H A, Denning G M, Ostedgaard L S, Sheppard D N, 
Cheng S H, Gregory R J and Smith A E 1992 CFTR: a chloride channel with novel regulation Neuron 8 
821-29. 
                                   
 
      Table 1: A table summarizing the values of cytoplasmic conductivity measured after using 
ion channel blockers in K562 and K562AR, plus controls and cells cultured in the presence 
of MDR modulator XR9576.  All results fit subject to an error margin of 10% or less. 
 
Cell Line σcyto (S/m) 
K562  
-control 0.28 
-with verapamil 0.22 
-with quinine 0.27 
-with NPPB 0.25 
-with XR9576 0.28 
K562AR  
-control 0.50 
-with verapamil 0.41 
-with quinine 0.34 
-with NPPB 0.25 
-with XR9576 0.55 
 
